Clinical Trial Update: A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 retrospective clinical study evaluating apatinib combined with radiotherapy/chemotherapy as second-line or higher treatment for recurrent/metastatic hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN